Santin, José Roberto; Uchôa, Flávia de Toni; Lima, Maria do Carmo Alves; Rabello, Marcelo M; Machado, Isabel Daufenback; Hernandes, Marcelo Zaldini; Amato, Angelica A; Milton, Flora Aparecida; Webb, Paul; Neves, Francisco de Assis Rocha; Galdino, Suely Lins; Pitta, Ivan da Rocha; Farsky, Sandra Helena Poliselli 
Source: European Journal of Pharmaceutical Sciences. Unidade: FCF
Subjects: INFLAMAÇÃO, NEUTRÓFILOS, INTERLEUCINA 1
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTIN, José Roberto et al. Chemical synthesis, docking studies and biological effects of a pan peroxisome proliferator-activated receptor agonist and cyclooxygenase inhibitor. European Journal of Pharmaceutical Sciences, v. 48, n. 4-5, p. 689-697, 2013Tradução . . Disponível em: https://doi.org/10.1016/j.ejps.2012.12.029. Acesso em: 04 nov. 2024.APA
Santin, J. R., Uchôa, F. de T., Lima, M. do C. A., Rabello, M. M., Machado, I. D., Hernandes, M. Z., et al. (2013). Chemical synthesis, docking studies and biological effects of a pan peroxisome proliferator-activated receptor agonist and cyclooxygenase inhibitor. European Journal of Pharmaceutical Sciences, 48( 4-5), 689-697. doi:10.1016/j.ejps.2012.12.029NLM
Santin JR, Uchôa F de T, Lima M do CA, Rabello MM, Machado ID, Hernandes MZ, Amato AA, Milton FA, Webb P, Neves F de AR, Galdino SL, Pitta I da R, Farsky SHP. Chemical synthesis, docking studies and biological effects of a pan peroxisome proliferator-activated receptor agonist and cyclooxygenase inhibitor [Internet]. European Journal of Pharmaceutical Sciences. 2013 ; 48( 4-5): 689-697.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1016/j.ejps.2012.12.029Vancouver
Santin JR, Uchôa F de T, Lima M do CA, Rabello MM, Machado ID, Hernandes MZ, Amato AA, Milton FA, Webb P, Neves F de AR, Galdino SL, Pitta I da R, Farsky SHP. Chemical synthesis, docking studies and biological effects of a pan peroxisome proliferator-activated receptor agonist and cyclooxygenase inhibitor [Internet]. European Journal of Pharmaceutical Sciences. 2013 ; 48( 4-5): 689-697.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1016/j.ejps.2012.12.029
